Thursday, May 1, 2025 at 8:30 AM
Online Streaming Available
May 1st, 2025 3.50 AMA PRA Category 1 Credit Hours
Description
The speaker will discuss off label use of biologics in Dermatology
Streams
| Name | |
|---|---|
| You must be signed in to view streams. Click here to sign into your Stony Brook Medicine CME Account. |
Dates and Times
Start: 5/1/2025 8:30 AM
End: 5/1/2025 12:00 PM
Objectives
1. Discuss the off-label uses of dupilumab and apremilast in numerous dermatologic conditions.
2. Explore the potential for combination therapy of dupilumab and apremilast with other immunosuppressants and biologics.
Speakers
Location
Stony Brook Dermatology
1320 Stony Brook Rd, Building F, Suite 200
Stony Brook, NY 11790
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credits ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Disclosure
Among all the planners, speakers, and reviewers for this educational activity only:
- Jay Wolverton, MD
| Speaker | Company | Relationship |
|---|---|---|
| Jay Wolverton, MD | ||
| Galderma | Researcher -- Clinical Trial - PI (nemolizumab in prurigo nodularis; concluded) | |
All of the relevant financial relationships listed for the above individual(s) have been mitigated.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Blair Bohnhorst
Department: Dermatology
Phone: (631) 444-3843
Email: blair.bohnhorst@stonybrookmedicine.edu